Zydus Lifesciences Company Profile

What is the competitive landscape for ZYDUS LIFESCIENCES, and what generic alternatives to ZYDUS LIFESCIENCES drugs are available?

ZYDUS LIFESCIENCES has sixty-seven approved drugs.

There is one US patent protecting ZYDUS LIFESCIENCES drugs.

There are four patent family members on ZYDUS LIFESCIENCES drugs in four countries and one hundred and sixty-two supplementary protection certificates in sixteen countries.

Summary for Zydus Lifesciences

International Patents:	4
US Patents:	1
Tradenames:	58
Ingredients:	58
NDAs:	67

Drugs and US Patents for Zydus Lifesciences

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Zydus Lifesciences	DOXYCYCLINE HYCLATE	doxycycline hyclate	TABLET;ORAL	207773-001	Oct 30, 2017	AB	RX	No	No
Zydus Lifesciences	ZIPRASIDONE HYDROCHLORIDE	ziprasidone hydrochloride	CAPSULE;ORAL	208988-004	Aug 22, 2017	AB	RX	No	No
Zydus Lifesciences	ROPINIROLE HYDROCHLORIDE	ropinirole hydrochloride	TABLET;ORAL	090411-004	Jun 1, 2009	AB	RX	No	No
Zydus Lifesciences	BACLOFEN	baclofen	TABLET;ORAL	211659-004	Feb 13, 2024	AB	RX	No	No
Zydus Lifesciences	VALSARTAN AND HYDROCHLOROTHIAZIDE	hydrochlorothiazide; valsartan	TABLET;ORAL	203000-003	Mar 15, 2019		DISCN	No	No
Zydus Lifesciences	MIDODRINE HYDROCHLORIDE	midodrine hydrochloride	TABLET;ORAL	213055-001	Sep 1, 2020	AB	RX	No	No
Zydus Lifesciences	FELBAMATE	felbamate	TABLET;ORAL	208970-001	May 30, 2017	AB	RX	No	No

International Patents for Zydus Lifesciences Drugs

Country	Patent Number	Estimated Expiration
South Africa	201606075
Philippines	12016501686
World Intellectual Property Organization (WIPO)	2015128877
India	651MU2014

Supplementary Protection Certificates for Zydus Lifesciences Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1261586	1290013-0	Sweden		PRODUCT NAME: SAXAGLIPTIN/METFORMIN; REG. NO/DATE: EU/1/11/731/001 20111124
1412357	SPC/GB07/046	United Kingdom		PRODUCT NAME: SITAGLIPTIN PHOSPHATE MONOHYDRATE; REGISTERED: UK EU/1/07/383/001 20070323; UK EU/1/07/383/002 20070323; UK EU/1/07/383/003 20070323; UK EU/1/07/383/004 20070323; UK EU/1/07/383/005 20070323; UK EU/1/07/383/006 20070323; UK EU/1/07/383/007 20070323; UK EU/1/07/383/008 20070323; UK EU/1/07/383/009 20070323; UK EU/1/07/383/010 20070323; UK EU/1/07/383/011 20070323; UK EU/1/07/383/012 20070323; UK EU/1/07/383/013 20070323; UK EU/1/07/383/014 20070323; UK EU/1/07/383/015 20070323; UK EU/1/07/383/016 20070323; UK EU/1/07/383/017 20070323; UK EU/1/07/383/018 20070323
1429780	SPC/GB12/058	United Kingdom		PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003
0809498	10C0038	France		PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
0347066	SPC/GB02/049	United Kingdom		PRODUCT NAME: ESCITALOPRAM OXALATE; REGISTERED: SE 17084/85/86/87 20011207; UK PL 13761/0008 20020610; UK PC 13761/0009 20020610; UK PL 13761/0010 20020610; UK PL 13761/0011 20020610; UK PL 13761/0012 20020610; UK PL 13761/0013 20020610; UK PL 13761/00014 20020610; UK PL 13761/0015 20020610
1534313	92923	Luxembourg		PRODUCT NAME: UNE SOLUTION D'IRRIGATION OCULAIRE COMPRENANT DE LA PHENYLEPHRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI ET DU KETOROLAC OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; FIRST REGISTRATION: 20150730
0480717	98C0025	Belgium		PRODUCT NAME: LOSARTAN POTASSIUM; HYDROCHLOROTHIAZIDE; NAT. REGISTRATION NO/DATE: NL 20 037 19950215; FIRST REGISTRATION: FR - NL 20 037 19950215

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Zydus
• Zydus Hlthcare
• Zydus Lifesciences
• Zydus Noveltech Inc
• Zydus Pharms
• Zydus Pharms Usa
• Zydus Pharms Usa Inc